{"schemaVersion":1,"target":{"type":"reading","id":"93ec281a38c26f023f87696c52d138b2bcbad6232a4e845e848aeecad0002904","revision":"2a608f40-2f33-419f-8090-de9825f2fbe6","revisionKind":"publication-id","title":"Researchers characterize when clinical LLMs recommend therapies despite genomic resistance","url":"https://escapemeridian.com/readings/researchers-characterize-when-clinical-llms-recommend-therapies-93ec281a"},"source":{"type":"source","id":"https://arxiv.org/abs/2611.19339","revision":"0731287b038d1a279a3d4a545d450f9ff8a7ee33445e7ae9c6b23277c1c47b60","revisionKind":"sha256-source-text","title":"From Mutation to Medication: Characterizing Failures of Clinical LLMs to Respect Genomic Resistance","url":"https://arxiv.org/abs/2611.19339"},"status":"available","items":[],"next":null,"scope":"Explicit citations in public readings to this reading. Shared topics are not citations. Other record types need an explicit reference adapter."}